3.15
0.05 (1.61%)
| Penutupan Terdahulu | 3.10 |
| Buka | 3.16 |
| Jumlah Dagangan | 229,641 |
| Purata Dagangan (3B) | 171,798 |
| Modal Pasaran | 12,616,475 |
| Harga / Jualan (P/S) | 1.86 |
| Harga / Buku (P/B) | 1.43 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 9 Aug 2023 - 14 Aug 2023 |
| Margin Operasi (TTM) | -2,073.29% |
| EPS Cair (TTM) | -1.43 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 2,170.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 121.86% |
| Nisbah Semasa (MRQ) | 0.760 |
| Aliran Tunai Operasi (OCF TTM) | -9.30 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -4.11 M |
| Pulangan Atas Aset (ROA TTM) | -73.20% |
| Pulangan Atas Ekuiti (ROE TTM) | -490.37% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Menaik | Bercampur | |
| Stok | Predictive Oncology Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.0 |
| Purata | 0.14 |
|
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.27% |
| % Dimiliki oleh Institusi | 2.07% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |